[KTTA] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
30-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 25.78%
YoY- -719.37%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 0 0 0 241 219 14 14 -
PBT -3,613 -3,598 -3,266 -5,118 -4,586 -2,658 -1,574 73.92%
Tax -162 -65 271,869 -1,215 671 -843 -1,616 -78.38%
NP -3,613 -3,763 -275,135 -3,902 -5,257 -1,815 41 -
Tax Rate - - - - - - - -
Total Cost 3,613 3,763 275,135 4,143 5,475 1,829 -28 -
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 0.00 0.00 0.00 -1,621.19 -2,404.65 -13,364.21 302.78 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -2.87 -2.88 -211.05 -3.00 -0.20 -0.08 0.00 -
EPS Diluted -2.87 -2.88 -211.05 -3.00 -0.20 -0.08 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.